This manual provides guidelines for performing a basic semen analysis, including procedures for assessing sperm concentration, motility, morphology, and other semen parameters. Safety protocols and quality control measures are outlined. Samples should be collected via masturbation and analyzed 30 minutes after ejaculation. Tests include examining liquefaction, viscosity, and wet preparations under a microscope to determine motility, vitality, and presence of debris. Sperm concentration is assessed using a hemocytometer, and morphology is examined on stained smears.
This document provides a practical guide to performing a semen analysis. It outlines the normal parameters that are evaluated which include appearance, volume, pH, viscosity, sperm concentration, motility, morphology and vitality. The document describes how to perform a macroscopic and microscopic evaluation of a semen sample, including assessing liquefaction, viscosity, and motility. It provides the normal reference values for semen parameters according to the WHO. The document offers guidance on procedures for assessing sperm concentration, morphology and provides an overview of the testing process.
This document provides information about evaluating abnormalities in a semen analysis panel, including:
- The indications, sample collection/transport procedures, and normal ranges for semen volume, pH, motility, concentration, morphology, and other tests.
- How to interpret abnormalities in these parameters, such as low/high volume, pH, motility, oligospermia/azoospermia, teratozoospermia and their potential causes.
- Quality control procedures like repeat testing, and transient defects that could affect initial semen analysis results.
Four clinical cases are then presented to demonstrate applying this evaluation and interpretation of semen analysis results.
The document discusses semen analysis, including:
1. It describes the different fractions that make up semen and their functions, such as nourishing sperm.
2. Semen analysis provides information on sperm production, male duct patency, accessory gland function, and ejaculation. It is used to evaluate male infertility, vasectomy effectiveness, and artificial insemination suitability.
3. Parameters examined in semen analysis include volume, pH, sperm count, motility, morphology, and presence of round cells. Tests are performed within a few hours of collection to assess these parameters.
4. Multiple factors can affect semen analysis results, so repeated testing is often needed for an accurate assessment
Semen analysis by Pandian M, Tutor Dept of Physiology DYPMCKOP, this ppt for ...Pandian M
This document provides information about performing and interpreting a normal semen analysis according to WHO guidelines. It discusses that a semen analysis examines the sperm count, morphology, and motility in the ejaculate. For a normal analysis, the sperm count should be between 35-200 million sperm per mL, most sperm should have a normal oval shape, and at least 50% of sperm should be actively motile. The document provides details on the procedures for examining each of these parameters under a microscope and calculating the sperm concentration in the ejaculate.
This document provides information about evaluating semen quality through various tests and examinations. It describes how to collect and transport semen samples, the normal characteristics of semen, and different abnormalities that can be detected through physical, microscopic, biochemical and other analyses of semen samples. The goal of semen analysis is to assess male fertility and detect any issues that may be causing infertility.
Semen analysis WHO 2010 BY DR ANAMIKA DEVAnamika Dev
The document provides information about semen analysis, including the typical components and fractions of semen, the structures and sizes of sperm cells, indications for semen analysis, the process of sample collection and handling, and the steps involved in an initial semen analysis. Key points include that semen is made up of contributions from various glands, liquefies within 15-30 minutes, and an analysis involves examining the sample under a microscope to assess characteristics like motility, viscosity, and presence of other cells.
Semen analysis provides important information about male fertility. It involves examining semen volume, color, pH, sperm count, motility, morphology, and the presence of any abnormalities. The analysis evaluates the main components of semen from the testes, prostate, and other glands. It is used to assess infertility, check for issues after vasectomy, and for sperm donations. Proper sample collection and handling is important for accuracy of the results.
This document discusses various methods for pregnancy testing from ancient to modern times. It begins by explaining what pregnancy is and the role of human chorionic gonadotropin (hCG) in pregnancy testing. Ancient methods like the Egyptians testing wheat and barley are described. The first major development was the Aschheim and Zondek test in 1928 which detected hCG in mice. Later tests used frogs, rabbits and other animals. Immunological tests developed in the 1960s allowed quicker and more accurate hCG detection without animals. Modern tests can detect hCG even earlier than previous methods, with some detecting hCG within 48 hours of fertilization.
This document provides a practical guide to performing a semen analysis. It outlines the normal parameters that are evaluated which include appearance, volume, pH, viscosity, sperm concentration, motility, morphology and vitality. The document describes how to perform a macroscopic and microscopic evaluation of a semen sample, including assessing liquefaction, viscosity, and motility. It provides the normal reference values for semen parameters according to the WHO. The document offers guidance on procedures for assessing sperm concentration, morphology and provides an overview of the testing process.
This document provides information about evaluating abnormalities in a semen analysis panel, including:
- The indications, sample collection/transport procedures, and normal ranges for semen volume, pH, motility, concentration, morphology, and other tests.
- How to interpret abnormalities in these parameters, such as low/high volume, pH, motility, oligospermia/azoospermia, teratozoospermia and their potential causes.
- Quality control procedures like repeat testing, and transient defects that could affect initial semen analysis results.
Four clinical cases are then presented to demonstrate applying this evaluation and interpretation of semen analysis results.
The document discusses semen analysis, including:
1. It describes the different fractions that make up semen and their functions, such as nourishing sperm.
2. Semen analysis provides information on sperm production, male duct patency, accessory gland function, and ejaculation. It is used to evaluate male infertility, vasectomy effectiveness, and artificial insemination suitability.
3. Parameters examined in semen analysis include volume, pH, sperm count, motility, morphology, and presence of round cells. Tests are performed within a few hours of collection to assess these parameters.
4. Multiple factors can affect semen analysis results, so repeated testing is often needed for an accurate assessment
Semen analysis by Pandian M, Tutor Dept of Physiology DYPMCKOP, this ppt for ...Pandian M
This document provides information about performing and interpreting a normal semen analysis according to WHO guidelines. It discusses that a semen analysis examines the sperm count, morphology, and motility in the ejaculate. For a normal analysis, the sperm count should be between 35-200 million sperm per mL, most sperm should have a normal oval shape, and at least 50% of sperm should be actively motile. The document provides details on the procedures for examining each of these parameters under a microscope and calculating the sperm concentration in the ejaculate.
This document provides information about evaluating semen quality through various tests and examinations. It describes how to collect and transport semen samples, the normal characteristics of semen, and different abnormalities that can be detected through physical, microscopic, biochemical and other analyses of semen samples. The goal of semen analysis is to assess male fertility and detect any issues that may be causing infertility.
Semen analysis WHO 2010 BY DR ANAMIKA DEVAnamika Dev
The document provides information about semen analysis, including the typical components and fractions of semen, the structures and sizes of sperm cells, indications for semen analysis, the process of sample collection and handling, and the steps involved in an initial semen analysis. Key points include that semen is made up of contributions from various glands, liquefies within 15-30 minutes, and an analysis involves examining the sample under a microscope to assess characteristics like motility, viscosity, and presence of other cells.
Semen analysis provides important information about male fertility. It involves examining semen volume, color, pH, sperm count, motility, morphology, and the presence of any abnormalities. The analysis evaluates the main components of semen from the testes, prostate, and other glands. It is used to assess infertility, check for issues after vasectomy, and for sperm donations. Proper sample collection and handling is important for accuracy of the results.
This document discusses various methods for pregnancy testing from ancient to modern times. It begins by explaining what pregnancy is and the role of human chorionic gonadotropin (hCG) in pregnancy testing. Ancient methods like the Egyptians testing wheat and barley are described. The first major development was the Aschheim and Zondek test in 1928 which detected hCG in mice. Later tests used frogs, rabbits and other animals. Immunological tests developed in the 1960s allowed quicker and more accurate hCG detection without animals. Modern tests can detect hCG even earlier than previous methods, with some detecting hCG within 48 hours of fertilization.
This document provides guidance for standardizing the process of semen analysis according to the 5th edition of the WHO laboratory manual. It outlines the aims, learning objectives, and steps for proper sample collection, handling, and analysis. Key points covered include assessing liquefaction time, viscosity, volume, pH, and motility using categories and acceptable difference tables. Case studies are presented to demonstrate how to document results for various clinical scenarios. The goal is to implement best practices for semen evaluation and quality control testing according to WHO standards.
A semen analysis measures the amount and quality of semen and sperm. It is one of the first tests done to evaluate male fertility issues. It determines semen volume, sperm concentration, motility, morphology, pH, and presence of white blood cells or other abnormalities. The sample is collected through masturbation and analyzed under a microscope to measure these parameters. Normal ranges are defined by the WHO for factors like sperm concentration, motility, and morphology. Abnormal results can indicate issues that reduce fertility. The analysis provides important information about male reproductive health and ability to conceive.
The document provides information about andrology laboratory services for male infertility evaluation and treatment. It discusses:
- Tests offered including semen analysis, specialized tests of sperm function and morphology, sperm processing for infertility treatments, and cryopreservation.
- Procedures for semen sample collection, transport, and analysis following WHO standards, including macroscopic examination of volume, pH, and microscopic examination of motility, concentration, vitality, and morphology.
- Uses of semen analysis to diagnose infertility issues, identify treatment options, and assess effectiveness of treatments like vasectomy reversal. Computer-assisted semen analysis is also discussed.
Semen analysis examines the constituents, volume, pH, motility, count, morphology, and function of sperm in semen. It is used to investigate infertility, check vasectomy effectiveness, and for other purposes. The test involves examining semen parameters like volume (>1.5mL), pH (>=7.2), motility (>32% progressively motile sperm), sperm count (>15 million/mL), and normal sperm morphology (>4%). Additional analyses include assessing sperm viability, antibodies, and function through tests like examining sperm's ability to penetrate cervical mucus or hamster eggs. Semen is collected and analyzed according to standardized WHO guidelines to evaluate male fertility potential.
This document discusses semen analysis, which plays a key role in evaluating male infertility. It describes the normal parameters for semen volume, pH, liquefaction time, viscosity, sperm concentration, motility, morphology, and viability. The roles of the prostate, seminal vesicles, and other glands in contributing to the semen are outlined. Standard procedures for semen collection and analysis are provided, along with causes of abnormal results and limitations of semen analysis. Advanced computer-assisted techniques for further evaluating sperm motility and function are also mentioned.
The document discusses semen analysis and spermatogenesis. It describes the two steps of spermatogenesis as spermatocytogenesis and spermiogenesis. The seminiferous tubules of the testis are identified as the site of sperm formation. Semen is defined as the fluid ejaculated during orgasm that contains sperm and secretions from various glands. Normal values for semen parameters according to WHO are provided. The steps of semen analysis and sample collection are outlined in detail.
This document discusses various sperm preparation techniques used prior to assisted reproductive technologies. It begins by explaining the reasons for processing sperm samples, such as removing components that could prevent pregnancy and selecting morphologically normal, motile sperm free of debris. Several migration-based techniques are described, including swim-up, density gradient centrifugation, and magnetic activated cell sorting. Glass wool filtration and zeta potential techniques are also covered. The document discusses preparation of epididymal and testicular sperm samples. It concludes by outlining methods for preparing sperm from retrograde ejaculation samples.
Ms. Doel Bose Pande discusses various semen preparation methods and principles. Common techniques include simple wash, swim-up, and density gradient centrifugation. The choice of method depends on factors like semen quality, intended use, and practical considerations. Density gradient is best for separating motile sperm from debris but is more time-consuming than direct swim-up. The goal is to recover high-quality sperm with minimal processing time and damage. Practical issues like sample volume and number of patients may also influence the choice of preparation technique.
Weak D testing is performed on all prenatal patients, Rh negative blood donors and transfusion candidates to identify those with the weak D phenotype. The procedure involves incubating patient red blood cells with anti-D, and if negative, adding anti-human globulin to look for weak agglutination indicating a weak D positive result. A true weak D will show at least 2+ agglutination; weaker results may be due to prior transfusions and require checking the transfusion history. All results are documented in the grouping register.
This document provides information about performing a semen analysis, including why it is requested, how to examine various parameters of a semen sample, and what the results may indicate. It discusses examining semen for volume, viscosity, pH, motility, concentration, and morphology. Abnormal results in these parameters can help locate problems in the male reproductive system, such as infections, obstructions, or issues with the testes, pituitary, or prostate. Precise techniques are described for tasks like measuring volume, assessing motility and concentration using a hemocytometer, and evaluating samples under a microscope.
This document discusses infertility, including definitions of infertility and sterility. It describes types of infertility as primary or secondary. Causes of infertility can include problems with the woman's menstrual cycle or the man's hormones. The process of spermatogenesis and sperm morphology are outlined. Tests for evaluating male and female fertility are mentioned. Common causes of infertility and treatment options like IUI, IVF, and ICSI are summarized at a high level.
This document provides information about semen analysis, including:
1. Semen analysis evaluates the quantity and quality of semen and sperm to detect male infertility and check the effectiveness of procedures like vasectomy.
2. Normal parameters include a sperm count of 15 million/ml or more, motility grades of 40% or more, and normal morphology of 4% or more according to WHO standards.
3. Samples should be collected after 2-7 days of abstinence and delivered to the lab within 1 hour to examine volume, pH, viscosity, sperm count, motility, morphology, and presence of other cells. Abnormal results can indicate conditions like infection or abnormalities of the reproductive organs.
This document discusses semen analysis, which is used to confirm vasectomy, check for infertility, and support reproductive technology like IVF. It also notes semen analysis can be used in medico-legal cases like rape. The document outlines details that should be included in a semen analysis report, such as collection date and time, quantity, color, consistency, and microscopy results including sperm count, motility grade, abnormal forms, and presence of pus cells.
This document discusses various sperm preparation methods used for intrauterine insemination (IUI). It describes the simple wash method, swim-up method, and density gradient centrifugation method. For each method, it provides the steps, including centrifugation speeds and times. It also covers preparing samples for retrograde ejaculation and samples from HIV-infected patients. The goal of sperm preparation is to select motile sperm and remove other seminal constituents like debris to maximize the chances of fertilization during IUI.
This document provides information about performing a semen analysis, including definitions of key terms, procedures, and normal ranges. It discusses:
1. The components and normal appearance of semen after liquefaction.
2. Procedures for assessing semen volume, viscosity, pH, sperm motility, morphology, concentration, and vitality under a microscope.
3. Factors that can affect the results, such as abstinence time, sample handling, and medical conditions.
The document is intended as a reference for medical professionals performing semen analyses to evaluate male fertility and identify potential issues.
CSF - Cerebrospinal fluid examination - from tapping to pathological diagnosisAshish Jawarkar
This is a series of notes on clinical pathology, useful for undergraduate and postgraduate students, as well as practising pathologists. Prepared from standard text books with data in tabular and easily readable format
Sma12 4668: Clinical Drug Testing in Primary CareCannabisCare.Ca
This document provides guidance on clinical drug testing in primary care. It discusses the reasons drug testing can be useful in primary care settings, including monitoring prescription medication use, evaluating unexplained symptoms, and detecting substance use disorders. The document covers important terminology, different testing methods and matrices, considerations for selecting laboratory or point-of-care testing, how to prepare the clinical setting and staff, and how to discuss testing with patients while being culturally sensitive. The goal is to help primary care providers appropriately incorporate and utilize drug testing in their practices.
This document provides guidance on methods for measuring the acute toxicity of effluents and receiving waters to freshwater and marine organisms. It discusses types of toxicity tests, health and safety considerations, quality assurance procedures, facility and equipment requirements, test organisms, dilution water, effluent and receiving water sampling and handling. The purpose is to help ensure accurate and reproducible toxicity test results.
This document provides guidance for standardizing the process of semen analysis according to the 5th edition of the WHO laboratory manual. It outlines the aims, learning objectives, and steps for proper sample collection, handling, and analysis. Key points covered include assessing liquefaction time, viscosity, volume, pH, and motility using categories and acceptable difference tables. Case studies are presented to demonstrate how to document results for various clinical scenarios. The goal is to implement best practices for semen evaluation and quality control testing according to WHO standards.
A semen analysis measures the amount and quality of semen and sperm. It is one of the first tests done to evaluate male fertility issues. It determines semen volume, sperm concentration, motility, morphology, pH, and presence of white blood cells or other abnormalities. The sample is collected through masturbation and analyzed under a microscope to measure these parameters. Normal ranges are defined by the WHO for factors like sperm concentration, motility, and morphology. Abnormal results can indicate issues that reduce fertility. The analysis provides important information about male reproductive health and ability to conceive.
The document provides information about andrology laboratory services for male infertility evaluation and treatment. It discusses:
- Tests offered including semen analysis, specialized tests of sperm function and morphology, sperm processing for infertility treatments, and cryopreservation.
- Procedures for semen sample collection, transport, and analysis following WHO standards, including macroscopic examination of volume, pH, and microscopic examination of motility, concentration, vitality, and morphology.
- Uses of semen analysis to diagnose infertility issues, identify treatment options, and assess effectiveness of treatments like vasectomy reversal. Computer-assisted semen analysis is also discussed.
Semen analysis examines the constituents, volume, pH, motility, count, morphology, and function of sperm in semen. It is used to investigate infertility, check vasectomy effectiveness, and for other purposes. The test involves examining semen parameters like volume (>1.5mL), pH (>=7.2), motility (>32% progressively motile sperm), sperm count (>15 million/mL), and normal sperm morphology (>4%). Additional analyses include assessing sperm viability, antibodies, and function through tests like examining sperm's ability to penetrate cervical mucus or hamster eggs. Semen is collected and analyzed according to standardized WHO guidelines to evaluate male fertility potential.
This document discusses semen analysis, which plays a key role in evaluating male infertility. It describes the normal parameters for semen volume, pH, liquefaction time, viscosity, sperm concentration, motility, morphology, and viability. The roles of the prostate, seminal vesicles, and other glands in contributing to the semen are outlined. Standard procedures for semen collection and analysis are provided, along with causes of abnormal results and limitations of semen analysis. Advanced computer-assisted techniques for further evaluating sperm motility and function are also mentioned.
The document discusses semen analysis and spermatogenesis. It describes the two steps of spermatogenesis as spermatocytogenesis and spermiogenesis. The seminiferous tubules of the testis are identified as the site of sperm formation. Semen is defined as the fluid ejaculated during orgasm that contains sperm and secretions from various glands. Normal values for semen parameters according to WHO are provided. The steps of semen analysis and sample collection are outlined in detail.
This document discusses various sperm preparation techniques used prior to assisted reproductive technologies. It begins by explaining the reasons for processing sperm samples, such as removing components that could prevent pregnancy and selecting morphologically normal, motile sperm free of debris. Several migration-based techniques are described, including swim-up, density gradient centrifugation, and magnetic activated cell sorting. Glass wool filtration and zeta potential techniques are also covered. The document discusses preparation of epididymal and testicular sperm samples. It concludes by outlining methods for preparing sperm from retrograde ejaculation samples.
Ms. Doel Bose Pande discusses various semen preparation methods and principles. Common techniques include simple wash, swim-up, and density gradient centrifugation. The choice of method depends on factors like semen quality, intended use, and practical considerations. Density gradient is best for separating motile sperm from debris but is more time-consuming than direct swim-up. The goal is to recover high-quality sperm with minimal processing time and damage. Practical issues like sample volume and number of patients may also influence the choice of preparation technique.
Weak D testing is performed on all prenatal patients, Rh negative blood donors and transfusion candidates to identify those with the weak D phenotype. The procedure involves incubating patient red blood cells with anti-D, and if negative, adding anti-human globulin to look for weak agglutination indicating a weak D positive result. A true weak D will show at least 2+ agglutination; weaker results may be due to prior transfusions and require checking the transfusion history. All results are documented in the grouping register.
This document provides information about performing a semen analysis, including why it is requested, how to examine various parameters of a semen sample, and what the results may indicate. It discusses examining semen for volume, viscosity, pH, motility, concentration, and morphology. Abnormal results in these parameters can help locate problems in the male reproductive system, such as infections, obstructions, or issues with the testes, pituitary, or prostate. Precise techniques are described for tasks like measuring volume, assessing motility and concentration using a hemocytometer, and evaluating samples under a microscope.
This document discusses infertility, including definitions of infertility and sterility. It describes types of infertility as primary or secondary. Causes of infertility can include problems with the woman's menstrual cycle or the man's hormones. The process of spermatogenesis and sperm morphology are outlined. Tests for evaluating male and female fertility are mentioned. Common causes of infertility and treatment options like IUI, IVF, and ICSI are summarized at a high level.
This document provides information about semen analysis, including:
1. Semen analysis evaluates the quantity and quality of semen and sperm to detect male infertility and check the effectiveness of procedures like vasectomy.
2. Normal parameters include a sperm count of 15 million/ml or more, motility grades of 40% or more, and normal morphology of 4% or more according to WHO standards.
3. Samples should be collected after 2-7 days of abstinence and delivered to the lab within 1 hour to examine volume, pH, viscosity, sperm count, motility, morphology, and presence of other cells. Abnormal results can indicate conditions like infection or abnormalities of the reproductive organs.
This document discusses semen analysis, which is used to confirm vasectomy, check for infertility, and support reproductive technology like IVF. It also notes semen analysis can be used in medico-legal cases like rape. The document outlines details that should be included in a semen analysis report, such as collection date and time, quantity, color, consistency, and microscopy results including sperm count, motility grade, abnormal forms, and presence of pus cells.
This document discusses various sperm preparation methods used for intrauterine insemination (IUI). It describes the simple wash method, swim-up method, and density gradient centrifugation method. For each method, it provides the steps, including centrifugation speeds and times. It also covers preparing samples for retrograde ejaculation and samples from HIV-infected patients. The goal of sperm preparation is to select motile sperm and remove other seminal constituents like debris to maximize the chances of fertilization during IUI.
This document provides information about performing a semen analysis, including definitions of key terms, procedures, and normal ranges. It discusses:
1. The components and normal appearance of semen after liquefaction.
2. Procedures for assessing semen volume, viscosity, pH, sperm motility, morphology, concentration, and vitality under a microscope.
3. Factors that can affect the results, such as abstinence time, sample handling, and medical conditions.
The document is intended as a reference for medical professionals performing semen analyses to evaluate male fertility and identify potential issues.
CSF - Cerebrospinal fluid examination - from tapping to pathological diagnosisAshish Jawarkar
This is a series of notes on clinical pathology, useful for undergraduate and postgraduate students, as well as practising pathologists. Prepared from standard text books with data in tabular and easily readable format
Sma12 4668: Clinical Drug Testing in Primary CareCannabisCare.Ca
This document provides guidance on clinical drug testing in primary care. It discusses the reasons drug testing can be useful in primary care settings, including monitoring prescription medication use, evaluating unexplained symptoms, and detecting substance use disorders. The document covers important terminology, different testing methods and matrices, considerations for selecting laboratory or point-of-care testing, how to prepare the clinical setting and staff, and how to discuss testing with patients while being culturally sensitive. The goal is to help primary care providers appropriately incorporate and utilize drug testing in their practices.
This document provides guidance on methods for measuring the acute toxicity of effluents and receiving waters to freshwater and marine organisms. It discusses types of toxicity tests, health and safety considerations, quality assurance procedures, facility and equipment requirements, test organisms, dilution water, effluent and receiving water sampling and handling. The purpose is to help ensure accurate and reproducible toxicity test results.
This document provides guidance for implementing a quality management system in drug testing laboratories. It discusses both management requirements, such as document control and auditing, and technical requirements, like personnel qualifications, method validation, and quality control. The guidance is based on international standards and is intended to help laboratories produce reliable, valid results that can withstand scientific and legal scrutiny.
This document provides standards for antimicrobial susceptibility testing of bacteria isolated from animals. It describes disk diffusion and dilution testing methods, as well as quality control guidelines. The document includes definitions of key terms, guidelines for selecting which antimicrobial agents to test and report, interpretive categories, reference strains for quality control, and specifics on performing beta-lactamase tests.
This document is a handbook on capsule endoscopy that was edited by Zhaoshen Li, Zhuan Liao, and Mark McAlindon. It contains 10 chapters written by various experts on different aspects of capsule endoscopy, including the history of capsule endoscopy, current capsule platforms, applications of capsule endoscopy in the small bowel, esophagus, colon, and pediatrics, as well as future directions and case presentations.
This document summarizes a systematic review of studies reporting on the global and regional incidence of preeclampsia and eclampsia between 2002-2010. The review identified 129 studies meeting inclusion criteria, from which 74 reports with data from over 39 million births across 40 countries were analyzed. Crude and model-based estimates were calculated. The overall estimates from the model were 4.6% of deliveries for preeclampsia and 1.4% for eclampsia, with significant regional variations. However, many countries lacked data, highlighting the need for improved data collection to better inform health policies.
WHO - Community management-of-opioid-overdoseEmergency Live
These guidelines were produced by the Management of Substance Abuse unit of the WHO Department of Mental Health and Substance Abuse in collaboration with the WHO HIV Department. Vladimir Poznyak and Nicolas Clark coordinated the development of these guidelines under the direction of Shekhar Saxena and in collaboration with Rachel Baggaley and Annette Verster. Members of the project’s WHO Steering Group included: Annabel Badderley, Rachel Baggaley, Nicolas Clark, Selma Khamassi, Elizabeth Mathai, Maggie Peden, Vladimir Poznyak, and Annette Verster (see Annex 7 for affiliations). The members of the project’s Guideline Development Group (GDG) were: Robert Balster (Chair), Barbara Broers, Jane Buxton, Paul Dietze, Kirsten Horsburgh, Raka Jain, Nadeem Ullah Khan, Walter Kloeck, Emran M Razaghi, Hendry Robert Sawe, John Strang, and Oanh Thi Hai Khuat (see Annex 7 for affiliations).
"Riesgo cancerígeno" esta expresión de la serie Monografías de la IARC se entiende que un agente que es capaz de causar cáncer. EstasMonografías evaluan los riesgos de cáncer, a pesar de la presencia histórica de los «riesgos» que figuran en el título.
La inclusión de un agente en las monografías no implica que se trata de un carcinógeno, sólo que los datos publicados han sido examinados. Igualmente, el hecho de que un agente aún no ha sido evaluado en una
Monografía no significa que no es cancerígeno. Del mismo modo, la identificación de los tipos de cáncer con pruebas suficientes o evidencia limitada en humanos no debe considerarse como excluyente de la posibilidad de que un agente puede causar cáncer en otros sitios.
Las evaluaciones de riesgo de cáncer son realizados por grupos de trabajo internacionales de científicos independientes y no son de naturaleza cualitativa. Ninguna recomendación se da para la regulación o legislación.
Cualquier persona que es consciente de los datos publicados que pueden alterar la evaluación del riesgo cancerígeno de un agente para el ser humano se le anima a hacer esta información disponible a la Sección de Monografías del IARC, Agencia Internacional para la Investigación del Cáncer, 150 cours Albert Thomas, 69372 Lyon Cedex 08 de Francia, con el fin de que el agente puede ser considerado para la re-evaluación de un futuro grupo de trabajo.
Aunque no se escatiman esfuerzos para preparar las monografías con la mayor precisión posible, los errores pueden ocurrir. Los lectores deben comunicar los errores a la Sección de Monografías del IARC, por lo que las correcciones pueden ser reportados en los volúmenes futuros.
This document discusses analytical method validation. It provides an overview of relevant regulations and quality standards from organizations like the FDA, ICH, and ISO. It also outlines common validation parameters that should be tested like specificity, precision, accuracy, linearity, range, limit of detection, limit of quantitation, ruggedness, robustness, and stability. The document provides guidance on planning a validation study, selecting validation criteria, testing performance characteristics, developing quality control plans, and documenting validation results. It also addresses method adjustments, revalidation, and verification of standard methods.
This document presents a review of the evidence on the validity of Kaltenborn's rule as applied to the glenohumeral joint. The review analyzed 30 studies on the direction of movement of the humeral head on the glenoid during shoulder movement. The studies showed poor methodological quality and inconsistent findings, precluding firm conclusions. While passive movement may follow Kaltenborn's rule, evidence suggests that active and control subsystems should also be considered in determining glide direction. Therefore, using Kaltenborn's indirect method to assess glide direction may need reconsideration.
This document discusses regulations and standards for analytical method validation. It provides an overview of requirements from the FDA, PIC/S, ICH, USP and ISO/IEC. Key points covered include method validation helping to ensure accurate and reliable data, as well as the interrelationship between instrument qualification, method validation, system suitability testing and quality control. The goal of method validation is to demonstrate that the analytical procedure is suitable for its intended purpose.
Acute heart failure: diagnosing and managing acute heart failure in adultsEmergency Live
The need for this guideline was identified as the NICE guidelines on chronic heart failure were being updated. We recognised at this time that there were important aspects of the diagnosis and management of acute heart failure that were not being addressed by the chronic heart failure guideline, which focussed on long term management rather than the immediate care of someone who is acutely unwell as a result of heart failure. The aim of this guideline is to provide guidance to the NHS on the diagnosis and management of acute heart failure.
Heart failure is a condition in which the heart does not pump enough blood to meet all the needs of the body. It is caused by heart muscle damage or dysfunction, valve problems, heart rhythm disturbances and other rarer causes. Acute heart failure can present as new-onset heart failure in people without known cardiac dysfunction, or as acute decompensation of chronic heart failure.
Acute heart failure is a common cause of admission to hospital (over 67,000 admissions in England and Wales per year) and is the leading cause of hospital admission in people 65 years or older in the UK.
This guideline includes important aspects of the diagnosis and management of acute heart failure that are not addressed by the NICE guideline on chronic heart failure (NICE clinical guideline 108). The guideline on chronic heart failure focused on long-term management rather than the immediate care of someone who is acutely unwell as a result of heart failure.
This guideline covers the care of adults (aged 18 years or older) who have a diagnosis of acute heart failure, have possible acute heart failure, or are being investigated for acute heart failure. It includes the following key clinical areas.
This document provides guidelines for researching and evaluating herbal medicines used in traditional medicine. It defines key terms related to herbal medicines and outlines approaches for assessing quality, safety, and efficacy. Specifically, it recommends verifying the botanical identity of herbal materials and standardizing herbal preparations to contain defined amounts of active ingredients when possible. It also provides guidance on acute and long-term toxicity testing to evaluate safety. The guidelines aim to improve research while respecting the history of established herbal medicine practices.
This document provides guidelines for managing clinical stage 1 renal masses. It discusses the epidemiology, diagnosis, and treatment options for renal cell carcinoma, including surveillance, radical nephrectomy, partial nephrectomy, and ablative therapies. It then describes the methodology used to analyze outcomes data from existing studies to determine treatment recommendations. The results of this analysis are meant to help guide clinical decision-making for patients with early-stage kidney cancer.
This document provides guidance on safety practices for high school chemistry laboratories. It outlines responsibilities for teachers, students, and schools to ensure a safe learning environment. The teacher is responsible for instructing students on basic safety procedures, hazards, and emergency responses. Students must learn to properly assess risks and select safe practices. While no federal law mandates safety programs in schools, supporting safety is important for administrators. With diligent planning and shared responsibility, the dangers of laboratory work can be avoided in an activity-based science program.
Current antiviral drugs have varying pharmacological constraints that may associate with limited efficacy, especially in severe COVID-19 patients, or safety concerns.
Recommendations for a public health approachclac.cab
This document provides recommendations for the prevention and treatment of HIV and other sexually transmitted infections among sex workers in low- and middle-income countries. It was published by the World Health Organization in December 2012 after reviewing evidence using the GRADE approach. The document includes good practice recommendations and specific technical recommendations regarding community empowerment, condom promotion, screening and treatment for sexually transmitted infections, voluntary counseling and testing for HIV, antiretroviral therapy, needle and syringe programs, and vaccination for hepatitis B. It also discusses operational considerations and identifies gaps in research that need to be addressed.
Linee guida e raccomandazioni per il trattamento della psoriasiMaria De Chiaro
This document provides clinical guidelines for the assessment and management of psoriasis. It was published by the National Clinical Guideline Centre at the request of the National Institute for Health and Clinical Excellence. The guidelines were developed by a group using an evidence-based approach to review available literature on psoriasis and make recommendations. The document covers epidemiology, clinical features, disease impacts, comorbidities, treatment approaches, and aims to provide guidance on best practices for assessing and managing patients with psoriasis.
This document summarizes the proceedings of an international workshop on dengue diagnostics held in 2004. The workshop aimed to review available rapid diagnostic tests for dengue, investigate new developments, and develop strategies for selecting optimal tests. Participants discussed current tests for acute dengue infection and agreed that virus isolation, RT-PCR detection of viral RNA, and detection of the NS1 antigen and IgM antibodies are suitable methods for diagnosis. However, concerns were raised about the performance and standardization of some commercial diagnostic kits. The workshop also addressed diagnostic needs, new technologies, quality assurance, and establishing a network of reference laboratories to advance dengue diagnostics.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Manual on Basic Semen Analysis
1. Manual on Basic Semen Analysis
2002
Final version 2002-03-11
This manual is revised to comply with the 1999 edition of the WHO laboratory manual
2002 NAFA and ESHRE-SIGA
3. Table of contents
Foreword
Semen analysis - overview...................................................................................... 1
Background and principles ........................................................................ 1
Safety in the andrology laboratory ............................................................ 1
The semen sample ..................................................................................... 1
Calibration ................................................................................................. 2
Procedure................................................................................................... 2
Equipment and materials ........................................................................... 6
Sperm concentration .............................................................................................. 7
Principles ................................................................................................... 7
Assessment of appropriate dilution ........................................................... 7
Procedure................................................................................................... 8
Calculations ............................................................................................... 9
Results ..................................................................................................... 10
Quality Control........................................................................................ 10
Reagents .................................................................................................. 10
Equipment and materials ......................................................................... 10
The confidence of sperm counts.............................................................. 11
Sperm motility....................................................................................................... 14
Principles ................................................................................................. 14
Procedure................................................................................................. 14
Sperm motility on video monitor............................................................. 14
Assessment of sperm motility.................................................................. 15
Calculations ............................................................................................. 15
Results ..................................................................................................... 15
Quality control......................................................................................... 16
Equipment ............................................................................................... 16
Video recording....................................................................................... 16
Sperm vitality ........................................................................................................ 18
Principles ................................................................................................. 18
Procedure................................................................................................. 18
Calculations and Results.......................................................................... 18
Reagents .................................................................................................. 18
Equipment and materials ......................................................................... 18
Sperm morphology ............................................................................................... 19
Principles ................................................................................................. 19
Background for assessment of sperm morphology.................................. 20
Preparation of smears .............................................................................. 21
Assessment of sperm morphology........................................................... 23
Immature germinal cells and mature spermatozoa .................................. 24
Quality control......................................................................................... 24
Calculations and Results.......................................................................... 24
Reagents .................................................................................................. 24
Equipment and materials ......................................................................... 25
Antisperm antibodies............................................................................................ 26
Principles ................................................................................................. 26
SpermMAR™ Tests ................................................................................ 27
Immunobead™ Test ................................................................................ 28
Reagents: ................................................................................................. 29
Quality control for SpermMAR™ and Immunobead™ Tests................. 29
Equipment and materials ......................................................................... 29
Quality Control and Quality Assurance............................................................. 30
Quality Control........................................................................................ 30
Quality Assurance ................................................................................... 31
Appendix I ............................................................................................................. 32
Appendix II............................................................................................................ 33
2002 NAFA and ESHRE-SIGA
4. Foreword
The Nordic Association for Andrology (NAFA) and the NAFA andrology laboratory quality group
decided in Turku in August 1995 to form the NAFA on semen analysis. Ulrik Kvist co-ordinated the
andrology laboratory quality group on semen work and Lars Björndahl acted as secretary.
analysis. The mission of this group was to develop a
This NAFA-ESHRE manual is an application of the
detailed, technical manual with methods based on
guidelines of the WHO (WHO Laboratory Manual
the WHO recommendations (1992). The aim was
for the Examination of Human Semen and Semen-
that the manual should constitute a basis for external
Cervical Mucus Interaction, 4th edition, Cambridge
quality control and for scientific collaboration in this
University Press, Cambridge, ISBN 0-521-64599-9)
field.
to facilitate the establishment of common,
Members in the NAFA group were: Ulrik Kvist (co- standardized methods and materials in andrology
ordinator), Aleksander Giwercman, Trine B Haugen, laboratories in the European countries, this being a
Jyrki Suominen, and Lars Björndahl (secretary). prerequisite for external quality control and
Other contributors were: Birute Zilaitiene, Margus scientific collaboration. No single method is
Punab, Øystein Magnus, Åse Strutz, Trine completely ideal, and the group has discussed
Henrichsen, Turid Vollen, Ingmarie Sundgren, Inger different possibilities to reach consensus on
Söderlund, Maiken Simonsen, Lene Andersen, methods, which are possible to use in a clinical
Majbrit Kvist, and Antero Horte. andrology laboratory and still are acceptable from a
methodological point of view (elimination of
This manual was first published in 1997. A second
sources of errors).
edition was published in 1998 and a third, re-edited
to comply with the 1999 edition of the WHO The methods in the manual also comply with the
recommendations, in 2000. curriculum of the standardised training course in
Basic Semen Analysis developed and implemented
At the annual business meeting of ESHRE Special
by the ESHRE-SIGA. Such courses have for
Interest Group on Andrology (SIGA) in Bologna,
instance been given as the joint ESHRE-NAFA
July 2000, it was decided that efforts should be
courses in Stockholm (1995, 1996 and 2001), Århus
made to make a joint NAFA-ESHRE Manual on
(1997), Göteborg (1998), Oslo (1998), and Helsinki
Basic Semen Analysis. A working group with
(2001).
representatives of the ESHRE SIGA was formed,
consisting of Usha Punjabi, David Mortimer,
Christopher Barratt, and Lars Björndahl for ESHRE,
Addresses
NAFA – Nordic Association for Andrology, President Marita Räsänen
http://www.ki.se/org/nafa
ESHRE – European Society of Human Reproduction and Embryology
SIGA – Special Interest Group on Andrology; co-ordinator Herman Tournaye
http://www.eshre.com
2002 NAFA and ESHRE-SIGA
5. Manual on Basic Semen Analysis (2002), Semen analysis – overview chapter 1, page 1
Semen analysis - overview
Background and principles
From the results of semen analysis we can different probabilities of achieving pregnancy
never predict whether a specific man can be- within a certain time period.
come a biological father or not. There are no
The aim of the basic semen analysis is to
specific properties one can measure in the
evaluate descriptive parameters of ejaculates
whole population of spermatozoa that spe-
obtained by masturbation. The qualities that
cifically reflect the fertilizing capacity of the
are assessed are visual appearance, smell,
very small population spermatozoa, which is
liquefaction, viscosity, volume, sperm concen-
able to reach the site of fertilization. However,
tration and total number of spermatozoa, sperm
analysis of semen can give us information
motility, and sperm vitality. Furthermore,
about problems in the genital organs of the
differential count with respect to sperm mor-
male; semen analysis can thus be used to focus
phology, assessment of sperm agglutina-
the continued infertility investigation. How-
tion/aggregation, and assessment of presence
ever, the results of semen analysis have been
of debris and other cell types in semen are also
used to categorize men into groups with
performed.
Safety in the andrology laboratory
All staff should be aware that semen samples guidelines as pointed out in Appendix II of the
might contain harmful viruses and should WHO 1999 Manual should be strictly
therefore be handled with due care. Safety observed.
The semen sample
Analysis of an ejaculate, obtained with
masturbation, begins at the laboratory 30 Instructions to the patients
minutes after ejaculation. Special rooms should An appropriate request form should accom-
be provided for sample collection. Before pany the sample containing relevant clinical
sample collection, the WHO manual recom- details. Before producing semen sample the
mends a maximum interval of abstinence be- patient should get verbal as well as written
tween 2 and 7 days, but recommends that the information about the purpose of the
interval should be “as constant as possible”. investigation and other important facts to avoid
Therefore, standardization of ”abstinence problems with the analyses. A short expla-
time” to 3-4 days is strongly advised1. Some nation of the male reproductive organs for
men have difficulties producing a semen laymen could be included in the written
sample at the laboratory. In these cases the material. The patient should be informed about
man may collect a first sample at home and de- the relevance of the abstinence time and the
liver it to the laboratory within one hour. In importance of collecting the complete
some cases it may be necessary for the man to ejaculate. If the sample cannot be produced in
use a special, non-spermicidal condom to the laboratory it should be transported
collect a sample at intercourse. protected from cooling (close to body) and
delivered to the laboratory preferably within 30
minutes, but at least within one hour after
ejaculation
1 The time of sexual abstinence, given in days, is very
imprecise. It is therefore advantageous if the time of
abstinence is given in hours. When results are to be used
in studies relating to abstinence time it is mandatory to
register it in hours.
2002 NAFA laboratory quality group
6. page 2; chapter 1 Manual on Basic Semen Analysis (2002), Semen analysis - overview
Calibration
Calibration shall always be done after changes these measurements and their results should be
have been done to the equipment or any time kept in a special binder.
errors are suspected. Balances for weighing semen and reagents
Automatic pipettes used for measurements should be calibrated at least every year by a
(sperm concentration, biochemistry) should be technologist or engineer certified by the
calibrated at least twice a year. Protocols for balance manufacturer. Results are stored in a
special binder.
Procedure
Overview of procedure
In the table below, the steps in basic semen analysis are given in an appropriate order to allow
efficiency and quality in the laboratory work. Details for the individual steps are given in the text
below. For microbiological culture, a sterile sample container and sterile disposable pipettes must be
used. Some steps are not mandatory, either because of agreed limitations (*), or because steps are
optional (#) according to the WHO manual (i.e. each laboratory can chose whether to perform them or
not).
Time after
ejaculation Task
0 - 5 minutes Register, weigh1 and label sample container; label corresponding laboratory
documents2
Put sample on an orbital mixer in the incubator (+37°C)
20-25 Assess liquefaction, visual appearance and smell
minutes
30 minutes Assess semen viscosity3.
Examine wet preparation for:
sperm motility and sperm aggregation/agglutination; other cells and debris
Perform antibody test
* Make smears for eosin-nigrosin stain if <40% motile spermatozoa and assess sperm
vitality
Make dilutions for determination of sperm concentration
Save 100 µL semen for assessment of inflammatory cells
Make smears to stain for morphological assessment
# Save and centrifuge semen for later biochemical analyses
Later Count spermatozoa in the improved Neubauer chamber
* If >1 million round cells/mL in semen: assess inflammatory cells
# Perform biochemical analyses of secretory contribution from prostate (e.g. zinc),
seminal vesicles (e.g. fructose) and epididymis (e.g.α-glucosidase)
Stain smear for morphology assessment
Assess morphology (differential counting)
1 Semen volume can also be determined by a graded pipette with 0.1 mL accuracy; weighing is then not necessary
2 Labels should in general comprise two unique identifiers, e.g. name and a unique number
3 The pipette used for determination of semen volume could be used to assess semen viscosity when semen is allowed to
drop from the pipette
2002 NAFA and ESHRE-SIGA
7. Manual on Basic Semen Analysis (2002), Semen analysis - overview chapter 1, page 3
Details of procedure
liquefaction is complete. If not (gel particles
Register, weigh and label sample container or mucous streaks), put the specimen back into
Initially, the sample should be registered. the incubator for some minutes (the
Sample container must be uniquely labelled1 examination must, however, begin within 60
concomitantly with the requisition, sample minutes after ejaculation - see Treatment of
record form, and optional questionnaire. If the some viscous samples below). Deviations from
sample is produced at the laboratory, the normal findings are noted on the sample record
container should be weighed and marked form. If the smell of the sample differs
before sample collection. When samples are strongly from the majority of samples, this is
not collected at the laboratory, the weight of also written on the sample record form.
empty containers should be marked on the
container before distribution to remitting The viscosity of the sample is assessed by
physicians/clinics or directly to patients. When estimation of how fast the sample runs out of a
the sample is collected, the time for ejaculation pipette. Fill a pipette4 (e.g. a 5-mL pipette)
should be clearly marked on the container, as with semen and let the semen flow back into
well as written in the protocol. The net weight the container. If the droplets form ”threads”
of the sample (total weight of sample and that are more than 2 cm long, note ”increased
container minus container weight) should be viscosity” on the sample record form.
noted in the protocol as semen volume (unit Treatment of viscous samples
mL; 1 decimal).
For samples with moderate to very high
Put sample on an orbital mixer in the viscosity a comment of the finding in the
sample record form as free text is sufficient.
incubator (+37°C)
High viscosity interferes with determination of
The sample should without delay be placed on sperm motility, concentration and antibody
a moving tray in an orbital mixer2 (+37°C). coating of spermatozoa. For samples where
The time of placement in the incubator should high viscosity hinders examination, addition of
be written on the sample record form. The a known volume of saline, phosphate buffer
sample should be left in the incubator until solution (PBS) or culture medium and careful
25-30 minutes after ejaculation, so that mixing with a wide bore pipette should give a
examination can begin at 30 minutes after homogenous dilution for examination. The
ejaculation. Take the container out of the original volume must be calculated and used to
incubator and check that the sample is well express the original sperm concentration in
mixed by ”swirling” the sample around the undiluted semen. If spermatozoa are to be used
bottom of the container for some 20 seconds. If for assisted fertilization, one must avoid
the sample was been produced outside the contamination of the sample and the medium
laboratory, it must be warmed up in the used for sperm preparation for assisted
incubator for 5-10 minutes before examination. fertilization should be used for dilution. N.B.
When semen samples are diluted the motility
Assessment of liquefaction, visual characteristics of the spermatozoa will be
appearance and semen viscosity affected.
Inspect the visual appearance of the sample
with respect to colour (without remark or Wet preparation
reddish-brown)3; opalescent or clear, presence Examination of a wet preparation
of gel particles or mucous streaks. Check that
Put 6 µL of well-mixed semen on a clean mic-
roscope slide and put a cover glass on top
1 Labelling should, in general, comprise two unique
(18 x 18 mm, #1½)5. This gives the preparation
identifiers, e.g. name and a number that is unique for the a depth of about 20 µm. Examination of this
sample
2 It is important to check that the sample containers used
wet preparation should begin as soon as the
allow a complete mixing of the samples with the orbital
”flow” in the preparation has ceased. If drifting
mixer used. does not cease within 60 seconds, the prepara-
3 A yellowish colour of the ejaculate usually depends on
an increased content of flavo proteins of seminal 4 If volume is not measured by weight, the pipette used
vesicular origin, indicating long time of sexual
abstinence, or from B-vitamins. Also icterus may give a for assessing the volume could be used
yellow colour. A reddish or brown discolouring mostly 5 If a 22 x 22 coverslip is used, the semen volume on the
depends on presence of erythrocytes (haemoglobin). microscope slide should be 10 µL.
2002 NAFA and ESHRE-SIGA
8. page 4; chapter 1 Manual on Basic Semen Analysis (2002), Semen analysis - overview
tion must be discarded and a new one pre- in semen from normal men, while presence of
pared. Phase contrast optics are needed. If large aggregates - often containing hundreds of
there is on average less than 1 spermatozoon spermatozoa, is abnormal. When the presence
per field of vision (40X objective with wide of sperm aggregates or agglutinates becomes
fields eyepieces), the sample should be treated clearly increased this should be noted as a free
as suspected azoospermia. For details and mo- comment in the report.
tility determination on video monitor, see
Other cells and debris
Chapter 3 in this manual
Other cells and debris that can be found in
Azoospermia or severe oligozoospermia
semen are assessed in several fields and
If there are no or only very few spermatozoa in unusual findings are expressed as free
the wet preparation you should note * comments in the report with a few different,
(asterisk) in the sample record form and as a standardized expressions:
free comment write how many motile and
• No debris is a very unusual situation,
immotile spermatozoa that were observed in
some debris is typical, but moderate
the wet preparation. If no motile spermatozoa
contamination with debris is not nec-
or only a few spermatozoa were found in the
essarily abnormal. Larger amounts of
wet preparation the sample should be
debris are, however, abnormal. Be careful
centrifuged6, and the pellet examined under the
to differentiate between particulate debris
microscope (40 X objective, phase contrast
and motile bacteria!
optics). If motile or immotile spermatozoa can
be identified when the whole area of a • Red blood cells (erythrocytes) should not
coverslip (at least 400 fields in a 22 x 22 mm be found in semen, although a few can be
coverslip) is scanned, the number of present without indicating pathology.
spermatozoa and whether they were motile or
immotile should be noted on the sample report • Epithelial cells (squamous, cubic and
form. transitional) are usual in semen in low
numbers. Increased presence is not related
Assessment of sperm motility to any specific functional impairment or
The first aspect of sperm function to assess in presence of infection.
the wet preparation is sperm motility. This • "Round cells" are often seen in semen
assessment should begin immediately to avoid and it is important that leukocytes are
temperature drop or dehydration of the differentiated from immature gametes or
preparation. For detailed methods, see large cell bodies (usually without nucleus)
Chapter 3 in this manual. with cytoplasm exfoliated from the semini-
Sperm aggregation and sperm agglutination ferous epithelium of the testis. Also cells
of prostatic origin appear round in the
Sperm aggregation or agglutination is deter- ejaculate. If there are more than 1 million
mined in 10 randomly chosen fields, away round cells/mL, counted in the Neubauer
from the coverslip edges. The average percen- chamber (at the same time as sperm
tage (estimated to nearest 5%) of spermatozoa concentration is determined), a special
trapped in clumps is estimated. Agglutination method for detection of leukocytes should
means spermatozoa adhering without other be used to determine the presence of ”in-
cells and debris. Multivalent antisperm flammatory cells”.
antibodies cause sperm agglutination. If the
clumps are very large, it can be difficult to • Bacteria and protozoa are usually not
determine whether the binding patterns are present in semen, but if signs of micro-
specific (e.g. head-to-head or tail-to-tail). If organisms are found, this must be noted in
cells, debris, and immotile spermatozoa are the report.
included, the clumping is most probably
caused by aggregation. The agglutinates are Smears for eosin-nigrosin stain
caused by sperm antibodies and often contain a According to the WHO manual, if the pro-
certain proportion motile spermatozoa, while portion of motile spermatozoa is less than
aggregates usually contain only dead sper- 50%, the proportion vital (living) spermatozoa
matozoa. Small aggregates of dead should be determined. The reason for assessing
spermatozoa and other material are often found the proportion living spermatozoa is to
differentiate between dead spermatozoa and
live, immotile spermatozoa. Clinically, this
6 At least at 1000 g for 15 minutes difference is only of interest when there are no
2002 NAFA and ESHRE-SIGA
9. Manual on Basic Semen Analysis (2002), Semen analysis - overview chapter 1, page 5
or very few motile spermatozoa. Therefore, a Make smears to stain for morphological
decision limit at less than 40% motile assessment
spermatozoa will not lead to any missed Two smears are made on clean microscope
diagnosis, but will decrease work load by slides from each semen sample for
reducing the number of vitality assessments of morphological evaluation. An aliquot (8-10-15
samples with living spermatozoa. For a
µL - volume adjusted to the sperm
detailed method for assessment of sperm
concentration to reduce overcrowding of the
vitality see Chapter 4 in this manual.
spermatozoa) of well-mixed semen is placed
on the slide and the droplet is spread with the
Antibody test
edge of a cover slip7. The smears are left to air
The secretory part of IgA-type antibodies bind dry and then fixed immediately and stored for
to cervical mucus. Presence of spermatozoa later staining for assessment of sperm
bound IgA therefore results in a reduced ability morphology (see Chapter 5 in this manual).
to penetrate cervical mucus. Smears from samples with suspected
Antibodies on sperm azoospermia should be fixed in separate vials
with fresh solutions to avoid the risk of
IgG and IgA on spermatozoa can be assessed contamination with spermatozoa from other
directly in semen with e.g. SpermMAR™ for smears.
IgG and IgA, and after washing with the
Immunobead™ test. Save and centrifuge semen for later
Antibodies in seminal plasma biochemical analyses
In semen samples lacking spermatozoa the The remaining semen volume is centrifuged
presence of antisperm antibodies can be (3000 g, 15 min) and the supernatant (seminal
assessed indirectly by exposing donor plasma) put into a labelled test tube for later
spermatozoa, without antibodies, to seminal biochemical analyses. The test tube is sealed
plasma from a man with suspected presence of and put in sample number order in a separate
antibodies. The donor spermatozoa are then rack in the freezer (-20°C). Methods for
processed as in a direct sperm antibody assay. biochemical analyses are not included in this
manual.
All methods are dependent on motile
spermatozoa. At least 200 motile spermatozoa Counting in an improved Neubauer
should be assessed. haemocytometer
Results from SpermMAR™ and Immuno- See Chapter 2 in this manual.
bead™ are not fully concordant. A positive
finding of IgA (i.e. more than 50% of motile Staining of smear for morphology
spermatozoa with beads attached) should be assessment
verified with a sperm-mucus interaction test.
See Chapter 5 in this manual
Dilution for determination of sperm
concentration
It is essential for the accuracy of the sperm
concentration assessment that the semen
sample is gently, but thoroughly mixed before
an exact volume is withdrawn with a positive
displacement pipette. See Chapter 2 in this
manual for a detailed method for assessment of
sperm concentration.
Save 100 µL for assessment of
inflammatory cells
To evaluate if a high concentration of round
cells (>1 million round cells/mL) in semen is
due to inflammatory cells, a specific method 7 An alternative method, using two opposed microscope
(cytological or immunocytochemical) for slides smearing the semen droplet in between them and
detection of leukocytes should be used. then pulling the slides apart, could also be used.
Irrespective of which method is used the smears must be
even and thin to allow good staining and easy
examination.
2002 NAFA and ESHRE-SIGA
10. page 6; chapter 1 Manual on Basic Semen Analysis (2002), Semen analysis - overview
Equipment and materials
The equipment and materials listed here are for semen collection and examination of the wet
preparation in general. In the following chapters, equipment and materials for the specific methods
described are listed separately.
Sample collection container (e.g. Sarstedt: 100 mL; # 75.563; Lid: #76.564)
Special condom for semen collection (Milex products Inc., Chicago, Illinois 60631, USA; Male Factor Pack®,
Hygiene®, FertiPro N.V., Belgium)
Phase contrast microscope (40X phase objectives)
Microscope slides (standard size); Coverslips (18 x 18 mm, # 1½ [thickness]; 22 x 22 mm; # 1½)
Pipettes for making
wet preparation: air displacement (positive displacement not needed): 6 µL
morphology smears: air displacement (positive displacement not needed): 8-15 µL
vitality smears: air displacement (positive displacement not needed): 15-50 µL
Pipette tips: plastic, for air displacement pipettes, volume 5-50 µL
Centrifuge (1000-3000 g)1
Laboratory balance, top loading 150 or 300 g capacity; resolution 0,01 g)
Test tubes for determination of inflammatory cells, e.g. styrene tubes 55 mm long, 11 mm OD
Test tubes with lid for freezing (biochemistry), e.g. styrene tubes 55 mm long, 11 mm OD
Incubator or heated chamber (+37°C)
Plastic gloves for laboratory use
1 The relative centrifugal force [RCF] (g) is calculated from the formula g=1118 • 10-8 • R •·N2 where R = distance in cm
from centre of rotor to the point where the RCF is required (ie. in the bottom of the tube); N = revolutions per minute
2002 NAFA and ESHRE-SIGA
11. Manual on Basic Semen Analysis (2002), Sperm concentration chapter 2, page 7
Sperm concentration
Principles
To count diluted and immobilized spermatozoa exact volume. Ordinary pipettes, which
is easy using the microscope. The problem is displace a volume of air, are calibrated to take
to ensure that these spermatozoa are repre- an exact volume of water. Since the viscosity
sentative and that the aliquot examined is of semen is higher than water and varies from
adequate and representative. This means that one sample to another air displacement pipettes
the spermatozoa should not be allowed to will take different volumes samples from
disappear by sedimentation, aggregation or by different semen specimens.
adhesion to the walls of the sample container,
In addition, to achieve a correct volume in the
pipette tips or test tubes, and that there are no
counting chamber, the coverslip must be
dilution errors. Thorough mixing is essential
mounted properly (tight), and the chambers
both before the semen is sampled for dilution,
must be correctly filled.
and before an aliquot is taken from the sperm
dilution to fill the counting chamber. The sperm concentration (106/mL semen) is
calculated by dividing the number of spermato-
Furthermore, the dilution must be exact.
zoa counted in the counting chambers, with a
Positive displacement pipettes are mandatory
factor depending on the dilution and the num-
to minimize the error when sampling a fixed
ber of squares counted. The total sperm num-
volume from the well-mixed semen for
ber (106/ejaculate) is the product of ejaculate
dilution. The reason for using a positive
volume and sperm concentration.
displacement pipette is that this pipette takes
an
Assessment of appropriate dilution
The wet preparation is used to estimate the
concentration and select the most appropriate Table 1: Dilution of the ejaculate
dilution. With the recommended method for Spermatozoa
Semen Diluent
making the wet preparation (6 µL semen, per field of vision Dilution
µL µL
cover slip 18 x 18 mm, “thickness” # 1½), the 40X objective
depth of the sample volume, surveyed in one 1+1
field of vision, is about 20 µm. Provided the Swim up 100 100
(1:2)
diameter of the field of vision is 500 µm1, the 1+4
given numbers of spermatozoa per field of < 15 100 400
(1:5)
vision can be used to chose the appropriate
1+9
dilution of the sample as given in Table 1 (4 15-40 50 450
(1:10)
spermatozoa per field approximately corre-
spond to the concentration of 1 million 1 + 19
40-200 50 950
sperm/mL). In older microscopes, the field (1:20)
diameter may be substantially smaller and then 1+ 49
> 200 50 2450
fewer spermatozoa are seen per field of vision (1:50)
(e.g. if the diameter is 250 µm, 1 spermato-
zoon per field of vision corresponds to 1 should be multiplied by four before going to
million sperm/mL, and the ”spermatozoa per Table 1).
field of vision” observed in the microscope
Thus, standard dilutions are 1 + 19 and 1 + 9;
for swim up preparations with < 10 mil-
lions/mL a dilution 1+ 1 could be used. When
1 The correct area of the microscopic field can be azoospermia is suspected, a pellet (after cen-
assessed with a stage micrometer, i.e. a microscope slide trifugation) is examined with regard to the
with a graded scale, usually with indications of 0.1 mm presence of motile and immotile spermatozoa
and 0.01 mm. Measure the diameter of the field and
in the pellet (see ”Azoospermia...” on page 4).
calculate the field area with the formula Area = π · r2
where r = diameter / 2.
2002 NAFA and ESHRE-SIGA
12. page 8; chapter 2 Manual on Basic Semen Analysis (2002), Sperm concentration
Dilutions can be kept for a maximum of four that can occur upon prolonged storage are
weeks in tested vials at +4°C, but should pref- sperm clumping and sperm adhesion to the test
erably be assessed the same day. The problems tube walls.
Procedure
(1) For every semen sample one dilution is prepared according to Table 1. The exact
volume of liquefied semen is withdrawn from the well-mixed semen sample with a
positive displacement pipette and added to the diluent in a test tube with a tight lid.
(2) Mount the coverslip1 on the counting chamber (improved Neubauer haemocytometer).
Interference patterns (>10 Newton’s rings/fringes or iridescence lines) should be seen
between the glass surfaces of both areas where the cover glass attaches to the Neubauer
slide. If too few lines are visible, then the distance between the cover glass and the
Neubauer slide is increased, and thereby the volume of the chamber is too large and the
result of the assessment will be incorrect.
(3) The tubes containing the diluted sample should be mixed for at least 10 seconds (on a
vortex mixer) immediately before filling the counting chamber. After mixing, an aliquot
of about 6-10 µL2 is taken with a pipette to one side of an improved Neubauer
haemocytometer. Then a second aliquot is taken to the other side. Each chamber should
be completely filled. If a chamber is overfilled, it must be discarded and a new chamber
filled. Removal of superfluous volume from the chamber must not be done, since this
can change the sperm concentration in the chamber. The counts from these two aliquots
are then compared.
(4) Let the chamber rest for 10-15 minutes in a humid box to allow the spermatozoa to
sediment to the grid of the counting chamber.
(5) Count the spermatozoa with a 20-40 X-objective3 (phase contrast) according to the
following criteria: One ”large square” in an improved Neubauer chamber is limited on
all sides by triple lines (see also Figure 1: the visual appearance of the central grid of an
improved Neubauer haemocytometer). To define each large square, you should always
use the uppermost lines and the leftmost lines as limits.
a) Determine the number of squares that should be counted. First count the number
of spermatozoa in the upper, left corner square.
< 10 sperm count all the grid (25 squares in each chamber)
10-40 sperm count 10 squares in each chamber
> 40 sperm count 5 squares in each chamber (e.g. 4 corners and
centre).
The purpose is that typically 200 spermatozoa should be counted in each chamber
and that this number is sufficient for a comparison between the two counts.
b) If a free sperm head can be recognized with certainty, it is recommended that it
should be included in the sperm count assessment. “Pin heads” should be counted
separately and commented in the report form. Immature germ cells should not be
counted (these will be assessed in differential morphology count), but round cells
and inflammatory cells should be counted separately in the counting chamber.
c) ”Borderline cases": only spermatozoa whose head is located on the upper or left
limiting lines (marked “OK” in Fig. 1) should be counted as ”belonging” to that
square. Thus, do not count spermatozoa located on the lower or right limiting
lines (marked “out” in Fig. 1).
1 This must be the special, thick coverslip for haemocytometers to achieve correct depth in the chamber.
2 the exact volume depends on what volume is needed to fill the area under the coverslip properly.
3 Note that a 40x objective with long working distance is necessary when using a Neubauer chamber.
2002 NAFA and ESHRE-SIGA
13. Manual on Basic Semen Analysis (2002), Sperm concentration chapter 2, page 9
Figure 1: The central field of a counting chamber in an improved Neubauer haemocytometer
One chamber consists of the 25 ”large squares”
seen in the figure. Each ”large” square is
surrounded by triplet lines and contains 16
small squares. These small squares can be used
when there are many spermatozoa to count in
the large square. With a 40X objective, only
about one large square can be seen in the same
field of vision. Each counting chamber (25
large squares) measures 1 mm x 1 mm and has
a depth of 0.1 mm (100 µm). Thus the total vol-
ume in one chamber is 0.1 mm3= 0.1 µL = 100
nL. (A Makler chamber also measures
1 mm x 1 mm, but has a depth of only 0.01
mm. Thus the total volume in a Makler
chamber is one tenth of the Neubauer = 0.01
µL = 10 nL).
Calculations
The counts from the two aliquots are compared procedure given here saves one division step
as described in Appendix I. Calculate the total and thereby reduces possible arithmetic error.1
number of counted spermatozoa (sum) and the
difference between the two counts. The assess-
ments are accepted if the difference between
the two counts is equal to or less than the value
obtained in Appendix I. If not, discard the
counts, vortex the sperm dilution thoroughly,
1 If your two counts are accepted, there are three calcula-
fill two new chambers and make new assess-
ments. tions to obtain the sperm concentration in millions/mL se-
men. These steps can be done step by step, but preferably
The sum of the two counts (total number of combined into one single calculation.
spermatozoa in both chambers) is divided by (1) Firstly, you calculate the mean number of counted
the appropriate factor (Table 2) to get the spermatozoa by dividing the sum of counted spermatozoa
sperm concentration in the semen sample by two (x ½)
(expressed as millions sperm/mL). (2) Secondly, the sperm concentration in the chamber
(i.e. in the diluted sample) must be calculated. To do this
N.B. In this manual, the total number of you must know the volume you have examined in the
spermatozoa counted is divided by the factors chamber. The volume of one large square in the improved
given in Table 2. In the WHO manual the total Neubauer haemocytometer is 4 nL (200 µm x 200 µm x
number of counted spermatozoa is first divided 100 µm (depth)). Thus:
Number of squares 5 10 25
by two to obtain an average and then this
Volume in nL 20 40 100
average is divided by another factor. Hence,
The mean number of counted spermatozoa is thus divided
the factors given in the WHO manual are by the volume within which they were counted
only half of the values given here. The (x 1/20; 1/40; 1/100)
The sperm concentration obtained is the number of sper-
Table 2: factor to divide the total number of matozoa per nL, which equals millions of spermato-
spermatozoa counted zoa/mL (spermatozoa/10-9 L = spermatozoa x 106/10-3 L)
(3) Thirdly, you have diluted the original semen sample
No of counted squares and to get the sperm concentration in semen you multiply
Dilution 25 10 5 with the dilution factor: (x 2; 5; 10; 20; 50)
1+1 100 40 20 Dilution 1+1 1+4 1+9 1+19 1+49
Factor x2 x5 x 10 x 20 x 50
1+4 40 16 8
These three steps can be carried out in a single division,
1+9 20 8 4 where the total number of spermatozoa in the two
1+19 10 4 2 chambers is divided by a single combined factor that is
1+49 4 1,6 0,8 given in Table 2.
2002 NAFA and ESHRE-SIGA
14. page 10; chapter 2 Manual on Basic Semen Analysis (2002), Sperm concentration
Results
Sperm concentration is noted in the sample Regarding the report of the result “no sperma-
record form, and the total number of spermato- tozoa” it is preferred that the result is not pre-
zoa in the ejaculate is calculated (multiply the sented as 0.0 million spermatozoa/mL, but that
concentration by the ejaculate volume). Be- an asterisk (*) is written in the place for con-
sides incomplete sample collection and varying centration and total sperm number. As a free
abstinence time, there are many other external comment, it should be stated if non or perhaps
factors that influence the total number of sper- single motile or immotile spermatozoa have
matozoa in an ejaculate, e.g. fever, some drugs been found in the ejaculate or in the centri-
and occupational exposure. For an appropriate fugation pellet. If no spermatozoa have been
evaluation of the quantitative aspects of sperm found in the 100 µL pellet, the maximum
production, the results from the laboratory number of spermatozoa that still may be
must contain data on sperm concentration, eja- present in the ejaculate should be given (details
culate volume (or total sperm number), absti- on calculations are given in the last sections of
nence time, and if the sample was collected this chapter), e.g. no spermatozoon found; it is
completely. likely to be less than 188 spermatozoa in the
entire sample.
Quality Control
Duplicate counting should be done to detect controls as well as repairs and adjustments
random errors in sampling and counting cham- should be recorded in a separate list for each
ber. pipette.
Calibration of the positive displacement Great care is needed when mixing and diluting
pipettes (some times called PCR pipette) and semen, mixing the diluted sample and
ordinary pipettes for measurements of diluents preparing counting chambers (attachment of
should be done regularly. Pipettes showing coverslip). Counting chambers should be
erroneous results should be amended according checked for accuracy when new and regularly
to instructions of the manufacturer or sent for after use (risk for wear and changed chamber
repair and adjustments. Results of calibration depth).
Reagents
Diluent: 50,0 g NaHCO3
10,0 mL 36-40% formaldehyde solution (a saturated formaldehyde solution)
• Dissolve constituents in distilled water (>10 MΩ/cm) and dilute to 1000 mL.
• Filter (to eliminate crystals) to a clean bottle
• Store at + 4°C (can be stored for at least 12 months).
• Should not contain solid particles
Equipment and materials
Vortex mixer
Phase contrast microscope (40X or 20X objective, and 10X to find focus easily)
Humid box: any box with lid and gauze or paper that should be kept wet, some sort of support to place the
counting chamber on above the moist material. N.B. the counting chamber must rest horizontally!
Calculator, laboratory counter, centrifuge, a working sheet / calculation sheet
Counting chamber: "improved" Neubauer haemocytometer with proper coverslip
Positive Displacement Pipette: e.g.: Finnpipette PCR 20-200 µL; tips: e.g. Labsystems 9403 080
Calibrated, adjustable pipette: e.g. Finnpipette Digital 200- 1000 µL; tips: e.g. blue Treff, or Finntip
Test tube Trombo-test-tube or ”Stockholm tube” (KEBO 104.112-250)
Lid to Trombo-test-tube or lid to ”Stockholm tube” (KEBO 103.811-12)
2002 NAFA and ESHRE-SIGA
15. Manual on Basic Semen Analysis (2002), Sperm concentration chapter 2, page 11
The confidence of sperm counts
What does it mean when no
spermatozoon is found?
Table 3: The risk to find no spermatozoon at various
If, theoretically, an entire semen sample is sperm concentrations assessed in 100 nL- and 10 nL-
examined and no spermatozoon is found, then chambers and in a wet preparation (approximately 40
the result is 0 spermatozoa. However, in a wet nL). The risk to find no spermatozoa is less than 5% at
preparation or in a counting chamber only a sperm concentrations ≥ 300 000/mL for the 10 nL-
small part of the whole sample is examined. chambers, ≥ 75 000/mL for the wet preparation and
Therefore, the finding “no spermatozoa” ≥ 30 000 for the 100 nL-chambers.
means that the sample with a certain proba- True sperm 1 Makler Wet prepa- Neubauer
bility contains less than a certain concentration conc. No dilution ration (2 chambers)
of spermatozoa. The precision of an assess- (sp-zoa/mL) (10 nL of (10 fields ≈ 1+1 dilution
ment depends on the true sperm concentration sample 40 nL) (100 nL of
and how large a proportion of the original analyzed) sample
analyzed)
sample that was examined under the micro- Risk to find no spermatozoon
scope. The larger proportion, the higher the
1 000 0.99 0.96 0.90
precision will be. An example: if a semen
10 000 0.90 0.67 0.37
sample is diluted 1+1 and assessed in an im-
proved Neubauer haemocytometer (two cham- 30 000 0.74 0.30 < 0.05
bers) you have examined 100 nL of the origi- 70 000 0.50 0.06
nal sample. If the same sample is examined 75 000 0.47 < 0.05
undiluted in a Makler chamber you have exa- 100 000 0.37
mined 10 nL. In the wet preparation you may 200 000 0.14
examine some 10 fields, which corresponds to 300 000 < 0.05
a volume of 40 nL. Table 3 shows the risk to
find no spermatozoon at various true sperm
concentrations. The risk to find no sperm is Table 4: There is always a risk to find no sperma-
tozoon even when a sample does contain
less than 5% only at sperm concentrations ≥ spermatozoa. In this table the critical sperm
300 000/mL for 10 nL-chambers, ≥ 75 000/mL numbers are given for when the risk to find no
for wet preparations (40 nL), and ≥ 30 000/mL spermatozoon goes under the limit of 5%, in
for 100 nL-chambers. relation to the number of fields examined. Thus,
the risk to find no spermatozoon is less than 5%
These numbers also mean that when no sper- when the sample contains 188 spermatozoa and
matozoa have been found there is a risk of 5% 400 fields have been examined. If the sample
to ignore a sperm concentration of 290 000/mL contains fewer spermatozoa, e.g. 100, the risk to
and 50% to ignore 70 000/mL when examined find none is greater than 5% (20%). Field
in the smaller, 10 nL-chambers. This empha- diameter 500 µm, preparation depth 20 µm.
sizes the need to investigate a centrifuged
No of fields assessed:
sperm pellet when no spermatozoa have been
found in the wet preparation. 4 40 400
Critical number of
18 750 1 875 188
Confidence in assessment of a spermatozoa
10 µL droplet from a centrifuged
sperm pellet and down 10 times means that some 400 such
fields are screened. When 400 fields have been
Under the 40X objective one microscopic field scanned a total volume of about 1600 nL (4 x
corresponds to 4 nL1. Each time the coverslip 400) have been assessed, i.e. about 1/62 of the
is scanned during screening in the microscope total pellet volume of 100 µL (100 000 nL). If
some 40 fields will be “passed”. Scanning up there are more than 188 spermatozoa in the
centrifuge pellet, the risk to find no
1 If the aperture has a diameter of 500 µm you view an
spermatozoon is less than 5%. However, with
lower concentration the probability to find no
area of 196 427 µm2 and with a 10 µL droplet under a
22x22 coverslip the depth is 20.7 µm giving a viewed spermatozoon is higher than 5%. Therefore,
volume of 4 058 442 µm3 ≈ 4 nL with no spermatozoon found, after examining a
2002 NAFA and ESHRE-SIGA
16. page 12; chapter 2 Manual on Basic Semen Analysis (2002), Sperm concentration
total volume of 1600nL, you can answer that all spermatozoa in both sides of an improved
the 100 µL-pellet, and thus the sample, Neubauer haemocytometer gives accurate
contains less than 188 spermatozoa (Table 4). results from 4 mill/mL and above. In contrast,
counting all spermatozoa in a 10 nL-chamber
Counting spermatozoa selected for gives accurate results within ± 10%, only when
the sperm concentration is 40 mill/mL and
assisted fertilization above. To obtain a result within ± 10% for
Spermatozoa selected by gradient centrifuga- samples in the concentration range of 4
tion or swim-up are to be assessed after 1+1 mill/mL you need to assess 10 of the 10 nL-
dilution (to immobilise the spermatozoa) in the chambers.
improved Neubauer haemocytometer. Both
chambers are counted. Table 5 gives the 95% confidence interval for
the sperm concentrations obtained after count-
Spermatozoa selected by swim up or gradient ing all spermatozoa in one Neubauer haemo-
centrifugation are used for ART and for cytometer and one 10 nL-chamber. When the
various experimental studies. Whenever the variation exceeds ±10%, awareness of the
results are to be related to, or evaluated as, a uncertainty should be given as the range in the
function of sperm number (e.g. in publica- report form. For instance, 2 mill/mL obtained
tions), Good Laboratory Praxis (GLP) calls for from an assessment in an improved Neubauer
a certainty of ± 10%, in the sperm concen- chamber is reported as 2 mill/mL (1.7-2.3) or
tration assessment. A concentration of 4.0 ±14%. If GLP, i.e. a uncertainty < ±10%, is
mill/mL should then mean 4.0 mill/mL ± 10%, desired assessment of two Neubauer chambers
i.e. 3.6 to 4.4 mill/mL with 95% confidence. is necessary. If the same result is obtained after
This certainty is easy to reach - it is simply a assessment in one 10 nL-chamber, the result
question of counting at least 400 spermatozoa. should be expressed as 2 mill/mL (1.1-2.9) or
One improved Neubauer haemocytometer ±44%. To achieve the result 2 mill/mL ±10%
(both chambers) takes 2 x 100 nL of a sperm with the 10 nL-chamber, 20 assessments are
suspension diluted 1+1 (to immobilize the needed. If your IVF protocol aims at adding
spermatozoa). The Makler chamber takes 10 e.g. 50 000 spermatozoa to every oocyte and
nL of undiluted sample. Thus, in the Neubauer an assessment in one 10 nL-chamber gives the
haemocytometer there are ten times more result 1 mill/mL (0.4-1.6), ±62%, you have
spermatozoa to count than in the 10 nL- actually 20 000-80 000 spermatozoa in a 50 µL
chamber. This is of special importance for the droplet. Only in 24% of the outcomes you add
low sperm concentrations obtained after sperm 50 000 ±10%, i.e. 45 000-55 000 spermatozoa.
selection. With the recommended routine In most cases (76%), you add either more than
assessment of sperm concentration, counting 55 000 or less than 45 000 spermatozoa.
2002 NAFA and ESHRE-SIGA
18. page 14; chapter 3 Manual on Basic Semen Analysis (2002), Sperm motility
Sperm motility
Principles
Ideally, all assessments are made on a video a temperature decrease or dehydration of the
monitor (see below) in order to minimize dif- preparation.
ferences in assessing videotaped samples for
Sperm motility is determined by counting all
QC purposes, and daily routine assessments of
motile and immotile spermatozoa in several
“live” samples. If video equipment is not
randomly chosen fields (but not fields close to
available assessments are made by eye via the
coverslip edges) using a 40X objective. If more
oculars and using a 40X phase contrast
than 25% of spermatozoa are involved in
objective.
clumping motility assessment is only done on
Assessment of sperm motility should begin free spermatozoa, and a comment is given on
immediately to avoid artefacts caused by either this in the report form. Spermatozoa with pin-
heads, “free tails”, should not be counted.
Procedure
field is very high, a smaller part of the field
Wet preparation should be used; a graticule or reticle in the
Put 6 µL well mixed undiluted semen (+37°C) ocular is of great help.
on a clean microscope slide (+37°C) and put When all progressive spermatozoa have been
on a coverslip (18 x 18 mm, “thickness” #1½). counted, non-progressive spermatozoa (WHO
This gives a preparation depth of about 20 µm. class c) and immotile spermatozoa (WHO class
Examination of this "wet preparation" should d) are counted in the same field.
begin as soon as the “flow” has ceased. If the
flow has not stopped within 60 seconds a new The four categories are expressed as
aliquot should be prepared and examined. percentages (rapid, slow and non-progressive,
and immotile.
If coverslips of the size 22 x 22 are used, the
volume must be 10 µL to give a depth of about Duplicated counting is important to detect and
20µm. minimise random errors due to variations due
to variation when withdrawing aliquots from
Counting the semen sample, and when making and as-
sessing the wet preparations. Assessment of
At least 200 spermatozoa are classified in sperm motility should therefore be repeated on
duplicate, i.e. at least 400 spermatozoa in total a second aliquot prepared in the same way.
(for criteria and a detailed method for as- The averages for two counts are calculated and
sessment of sperm motility: see below, given as results. If the difference between the
Assessment of sperm motility). At least five two motility counts is too large, you have de-
fields should be assessed in each count. tected a random error and two new as-
Within each field, all rapidly progressive sessments should be done (see below for
spermatozoa (WHO class a) and slowly details on method and comparisons of du-
progressive spermatozoa (WHO class b) are plicate counts).
counted first - and care should be taken to
count only, and all, cells which are present in
the field at the same time. N.B. If the number
of progressively motile spermatozoa in the
Sperm motility on video monitor
On the monitor screen, either a black mask in the specimen can be attached to facilitate
with a circular opening or an acetate transpar- estimation of velocity.
ency with a circular field drawn upon it should
Use the 10X-phase contrast objective and
be mounted. In the circular field so defined, a
corresponding condenser phase ring. Check in
grid with squares corresponding to 25 x 25 µm
the oculars that the sample is focused correctly.
2002 NAFA and ESHRE-SIGA
19. Manual on Basic Semen Analysis (2002), Sperm motility chapter 3, page 15
Adjust the focus while examining the picture on the screen.
Assessment of sperm motility
Sperm motility is assessed by categorisation into four groups of motility at 37°C:
WHO category ”code” corresponding velocity
rapid progressive a ≥25 µm/s (≥ 1 monitor square, or a 5 sperm head lengths)
slow progressive b 5-24 µm/s
non progressive c <5 µm/s (< 1 sperm head length)
immotile d -
(1) Chose randomly a field of vision (if same field.
the sperm concentration is very high, (2) Count at least five different fields. At
only count those spermatozoa in a least 200 spermatozoa should be
smaller field, e.g. in the most central counted in each preparation.
four squares). First, count all rapid (3) Repeat the assessment of the motility
and slow progressive spermatozoa. of at least 200 spermatozoa in a new,
Thereafter, count non-progressive separate preparation from the same
and immotile spermatozoa in the semen sample.
Calculations
For each of the two preparations, the total the difference in proportion between the
number of spermatozoa in each motility group two assessments in this group.
is divided with the total of number of
• The assessments are accepted if the diffe-
spermatozoa assessed to obtain percentages for
rence between the two motility percentages
the four groups (a-d).
is equal or below the value obtained in
To check that the difference between the two Appendix II. If not, discard the assessments
counts is within an acceptable range, the and make two new wet preparations and re-
following calculations are done: count.
• Calculate the percentage of spermatozoa in When two accepted counts have been
each motility group (a-d). achieved, the average proportions (a-d) are
rounded to integers (no decimals). 0.5% is
• Calculate the average in each group for the
rounded to the nearest even number. Finally,
two assessments.
the sum of percentages (a-d) should add up to
• Then, select the group of motile sperma- 100%. If necessary the group with the highest
tozoa with the highest average proportion proportion is adjusted (decreased or increased)
(i.e. one of group a, b, c, or d) and calculate to obtain a sum of 100%.
Results
Percentages for the four categories of sperm gressive spermatozoa (a+b) are written on the
motility, percentage motile spermatozoa sample report form.
(a+b+c), and (optionally) percentage pro-
2002 NAFA and ESHRE-SIGA
20. page 16; chapter 3 Manual on Basic Semen Analysis (2002), Sperm motility
Quality control
Duplicate counting is used to decrease the risk Some aspects of Internal Quality Control can
of random errors. be covered by repeated examination of video-
tapes with known values by all technologists in
In semen samples recorded on videotapes the
each laboratory.
velocity of individual spermatozoa can be
measured ”frame by frame” to classify One technologist at each laboratory, assessing
spermatozoa into the different groups (a-d) videotapes sent out to participating labora-
more objectively. tories, is the basis for External Quality Control.
Equipment
• Phase contrast microscope (10X objective) • A total magnification on the monitor: 100
with +37°C microscope stage. Triocular µm = 75-88 mm (further magnification is
tube (oculars and photo tube with additional usually needed ”above” the 10X magnifi-
10X magnification). cation in the objective; typically about
another 10X in the photo tube). Check the
• Black & white (or colour) video camera,
overall on-screen magnification with a
e.g. Panasonic: (1/2 inch; WV-BL200);
micrometer scale.
connect to text generator.
• Micrometer scale mounted on a microscope
• Monitor 13 cm (black & white; e.g. Pana-
slide (for calibration).
sonic WV5340 or WV5370 [Size normal]).
A black mask with a circular opening (∅ • Microscope slides; cover glass 18 x 18 mm,
about 13 cm) #1½
CONNECTIONS:
• Videotapes (30-60 min recording time; high
In: connect from video recorder;
quality).
switch: 75 Ω.
• 4-channel cell counter.
Video recording
Extra equipment needed for video recording:
• Text generator connected to video recorder (e.g. Hama Video Script 550)
Input: Video camera.
Output: connect to video recorder (SCART multi pin socket: In).
• Video Cassette Recorder (VHS) with possibility to move frame by frame (1/25 s) - ”ordinary home
video” and two SCART multi pin sockets (In and Out).
Input from text generator.
Output to monitor.
• Videotapes (30-60 min recording time; high quality).
3. Reset the counter so that used time is
Procedure zero. Check that the video recorder shows
1. Turn on camera, monitor, video recorder, ”used time” on the panel.
and text generator. The text generator
4. First record the image of a micrometer
starts to show a demonstration - turn it off
scale, to allow ”calibration”. Record for
by pressing three times on MODE.
about 10 s, then set recorder for ”pause”.
2. Put the videotape to be used into the video
5. Set the beam splitter so that the light does
recorder. Wind the tape first forward and
not go to the camera, i.e. make the picture
then back to start again before first re-
black. Get the ”start text” from the sign
cording.
generator (e.g. ”Andrology laboratory,
XXXXX Hospital, Quality control”).
When the text is visible on the monitor,
2002 NAFA and ESHRE-SIGA
21. Manual on Basic Semen Analysis (2002), Sperm motility chapter 3, page 17
start recording for about 10 s. Record a that field. Repeat step 10-12 until more
further 5 s without text but with black than 200 spermatozoa that can be assessed
background. have been recorded.
6. Now put an aliquot of the sample on the 11. Change the field of view in the
microscope slide (pre-heated to 37°C) and microscope, then set the beam splitter so
focus the microscope. Set the beam that the light goes to the camera.
splitter so that the light goes to the camera
12. Record 5 s with black background after
and adjust the focus. Deselect the camera
each field of view has been recorded.
at the beam splitter.
13. After one sample has been completed,
7. Note the start time and number for the
make a longer period of ”black recording”
sample to be recorded. Get the ”sample
(10 s).
text” from the text generator (e.g.
”Sample 1”). 14. Repeat from step 7 until the tape is com-
pleted (about 10-12 samples should be
8. With the sample text turned on, start re-
possible with samples having reasonable
cording for 5 s.
sperm concentrations in a 60 minute
9. Turn off the sample text and reset the videotape).
beam splitter so that the light goes to the
15. Record a message ”End of tape” directly
camera.
after last field of the last sample.
10. Check focus. Record for 10-15 s. Estimate
how many spermatozoa can be counted in
2002 NAFA and ESHRE-SIGA
22. chapter 4, page 18 Manual for Laboratory Andrology (2002), Sperm vitality
Sperm vitality
Principles
A cell with an intact cell membrane does not up the red stain. Nigrosin is used as a
take up the stain Eosin Y, while a dead cell background stain to provide contrast for the
(i.e. one with damaged cell membrane) takes unstained (white) live cells.
Procedure
(1) Mix one drop (50 µL) of undiluted, well-mixed liquefied semen with one drop (50 µL) of
eosin-nigrosin staining solution (e.g. in a porcelain spotting plate) and incubate for 30
seconds.
(2) Then place a drop of the solution (12-15 µL per microscope slide) on a clean microscope
slide, and make a smear1.
(3) Let the smear air dry and examine directly or mount permanently the same day, and
examine after the mountant has dried (e.g. overnight). Mounted smears are stored at room
temperature.
(4) At least 200 spermatozoa should be assessed2 at 1000X (or 1250X) magnification under
oil immersion with a high-resolution 100 X objective (not phase contrast) with correct
adjustment of the bright field optics (Köhler illumination). Spermatozoa that are white
(unstained) are classified as "live" and those that show any pink or red colouration are
classified as "dead".
(5) WHO does not specify duplicate counting for vitality assessment, but if this is done, com-
parison should be done as for motility or morphology (comparison of proportions;
Appendix II).
Calculations and Results
The result is the proportion of vital (“live”) The proportion of live spermatozoa is usually
spermatozoa, expressed as an integer somewhat higher than the proportion of motile
percentage (i.e. without decimals). spermatozoa in the sample.
Reagents
Reagents:
0.67 g eosin Y (C.I. 45380, Europe M 15935), 10 g Nigrosin (C.I. 50420, Europe M 15924) and 0.9 g
sodium chloride in 100 mL distilled water
• Dissolve 0.67 g eosin Y and 0.9 g sodium chloride in 100 ml distilled water under gentle heating and add 10
g nigrosin
• Bring the solution to boil and allow to cool to room temperature
• Filter the solution through filter paper (eg. Munktell Class II)
• Store in a sealed glass bottle
• The staining solution should be at room temperature when used
Mounting:
• Use Merck Entellan-medium or other equivalent medium for quick and permanent mounting.
Equipment and materials
Microscope with 100X objective (oil immersion)
Microscope slides (standard size) and cover slips (e.g. 24 x 60 mm)
1 The drop is smeared by sliding a cover slip in front of the drop. If two smears are made simultaneously by spreading
between two microscope slides without feathering, one drop of 20-30µL is used. Don’t make the smears too thick, since the
background stain could be too dark and cover the sperm.
2 Since this method dilutes the original semen sample 2 times, patience is needed to find 200 sperm in samples with low
sperm concentration.
2002 NAFA and ESHRE-SIGA
23. Manual on Basic Semen Analysis (2002), Sperm morphology chapter 5, page 19
Sperm morphology
Principles
The morphology seen with the microscope is Consequently, the pH during staining affects the
not the true morphology of a living final results. Spontaneous oxidation of
spermatozoon, but an image we create. This haematoxylin to haematein takes weeks.
image comprises a number of factors: spermio- Therefore haematoxylin is oxidized artificially
genesis, sperm transport, maturation and by adding an oxidizing agent; usually sodium
ageing, time in seminal plasma, smearing iodate or mercuric oxide and most of the
technique, fixation, staining, mounting, and the commercially available haematoxylins are
optics and illumination used (i.e. the quality of artificially oxidized and contain a mixture of
the microscope). The criteria for classification haematoxylin and haematein. Over-oxidation
are only the final step by which we describe can occur and then the coloured haematein is
the image created during preparation. With transformed to colourless oxyhaematein. This
standardized and quality controlled methods, explains the spontaneous fading of colour in
we can minimize technique dependent sources haematoxylin-stained smears during long-term
of errors and focus our efforts on classifi- (years) storage.
cations of variations in sperm morphology.
Haematoxylin and haematein are charged
It is of great importance that the preparations positively but only weakly, and it is therefore
(smearing and staining) are of high quality necessary to use "mordants" which behave as
when assessing sperm morphology. Even binding reagents, linking haematoxylin stain to
small, technique-dependent artefacts influence the cells. The type of mordant also has an effect
the appearance of the spermatozoa. on the colour of the stained cells. Mordants are
metallic compounds bound both to haematoxylin
Although human spermatozoa show large
stain and to negatively charged tissue
variations in morphology, observations on
components, usually the phosphoric acid
spermatozoa obtained from post-coital cervical
residues of the DNA, but also to carboxyl
mucus have helped to define the morphology
groups. Aluminium ammonium sulphate is the
of an ideal spermatozoon. Presumably, the
most commonly used mordant and it is a
fertilizing spermatozoon is selected among
component of both Harris' and Mayer's haema-
these ideal spermatozoa.
toxylins.
Papanicolaou stain (haematoxylin, orange G6,
Smears stained with Harris' haematoxylin (the
and EA50) gives a clear difference between
usual haematoxylin in the Papanicolaou method)
basophilic and acidophilic cell constituents and
are stable for months to years if stored in the
thereby enables a detailed examination of
dark. However, the colour intensity of haema-
chromatin pattern, which is useful in the
toxylin will fade during a prolonged storage as
evaluation of sperm morphology and
explained above.
assessment of presence of immature
spermatozoa. Cytoplasmic staining can vary Cytoplasmic staining: this is done with OG6
between red and green dependent on ionic (orange G6), which is an acidic solution
strength, pH, and composition of the cell allowing binding of OG6 to negatively charged
department and the stain (OG6 and EA50). cytoplasmic proteins.
Nuclear staining: there are several hae- Cytoplasmic and nucleolar staining: EA 50 is
matoxylin stains depending on how the a polychromatic dye mixture: Light green (SF
haematoxylin is oxidized and which type of yellowish), Eosin (Eosin Y) and Bismarck
mordant (the reagent that facilitates binding of brown Y. Light green and Eosin are acidic dyes:
the dye to cell structures) is used. Light green binds to side-chains of basic
Haematoxylin itself is in fact colourless. It is proteins. Eosin is a xantheine dye; negatively
the oxidized form, haematein that gives the charged in aqueous solutions; stains cytoplasmic
staining. The colour of haematein depends on components, nucleoli (which do not occur in
pH. Under acid conditions it is red, whilst spermatozoa) and cilia. Its absorption maximum
under alkaline conditions it is blue. is 515-520 nm.
2002 NAFA and ESHRE-SIGA